 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
 |
|
|
 |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alpha-fetoprotein (AFP) is used for the diagnosis, therapy control and follow-up
of hepatocellular carcinomas and germ cell tumors
|
|
|
|
|
|
|
|
BRAHMS Kryptor AFP |
|
|
|
- TRACE technology (Time resolved amplified cryptate emission)
- Sample matrix: Serum, plasma (EDTA/heparin), amniotic Fluid
- Diluent included in kit
- Sample volume: 14 µl
- Incubation time: 9 min
- Direct measuring range: 0.23 – 700 ng/ml
- Range with automated dilution: 0.23 – 500 000 ng/ml
- Detection Limit: 0.23 ng/ml
- Intra – assay and Inter-assay coefficients of variation are 2.63 – 4.63 % and
2.81 – 5.22 % , respectively
|
|
|
|
DiaSorin Liaison AFP |
|
|
|
- 2-step immunoluminometric sandwich assay using directly coated magnetic
microparticles
- Sample matrix: Serum, plasma, Amniotic Fluid
- Sample volume: 25 µl
- Incubation time: 20 min (10 min + 10 min)
- Measuring range: 0.2 0 1000 IU/ml
- Range with automated dilution: 0.23 – 500 000 ng/ml
- Detection Limit: 0.2 IU/ml
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
816.075 |
BRAHMS AFP |
KRYPTOR TRACE Technology |
75 test kit |
Serum, plasma (heparin/EDTA) Amniotic Fluid |
|
314471 |
Liaison AFP |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum, plasma, Amniotic Fluid |
|
324471 |
IRMA-mat AFP |
IRMA Coated Tubes (RIA) |
100 Tubes |
Serum, Amniotic Fluid |
|
|
|
|
|
|
|
|
|
Back To Top |
|
|
|
CA 125 II |
|
|
|
|
|
|
Cancer antigen (CA 125 II) is used for the evaluation of the initial treatment
efficacy, the long-term follow-up of patients in remission and the early
detection of recurrence of disease or metastasis |
|
|
|
|
|
|
|
BRAHMS Kryptor CA 125 II |
|
|
|
- TRACE technology (Time resolved amplified cryptate emission)
- Sample matrix: Serum, plasma (EDTA/heparin)
- Diluent included in kit
- Sample volume: 50 µl
- Incubation time: 29 min
- Direct measuring range: 0 – 600 U/ml
- Range with automated dilution: 0 – 100 000 U/ml
- Detection Limit: 1 U/ml
- Inter-assay precision in the clinically relevant range is between 2.2 and 4.5 % CV
|
|
|
|
DiaSorin Liaison CA 125 II |
|
|
|
- 2-step immunoluminometric sandwich assay using directly coated magnetic
microparticles
- Sample matrix: Serum, plasma
- Sample volume: 100 µl
- Incubation time: 20 min (10 min + 10 min)
- Measuring range: 0.2 - 1000 U/ml
- Detection Limit: 0.2 U/ml
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
805.075 |
BRAHMS CA 125 II |
KRYPTOR TRACE Technology |
75 test kit |
Serum, plasma (heparin/EDTA) |
|
314211 |
Liaison CA 125 II |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum, plasma |
|
R0053 |
CA 125II IRMA |
IRMA, Coated Tubes (RIA) |
50 Tubes |
Serum, Plasma |
|
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
|
|
|
|
|
CA15-3 is used for therapy monitoring of breast cancer patients, the long-term
follow-up of patients in remission and the early detection of recurrence of
disease or metastasis |
|
|
|
|
|
|
|
BRAHMS Kryptor CA 15-3 |
|
|
|
- TRACE technology (Time resolved amplified cryptate emission)
- Sample matrix: Serum
- Diluent included in kit
- Sample volume: 8 µl
- Incubation time: 14 min
- Direct measuring range: 0.3 – 500 U/ml
- Range with automated dilution: 0.3 – 40 000 U/ml
- Detection Limit: 0.3 U/ml
- Intra – assay and Inter-assay coefficients of variation are 0.4 – 1.0 % and 1.3 – 2.1 % , respectively
|
|
|
|
DiaSorin Liaison CA 15-3 |
|
|
|
- 2-step immunoluminometric sandwich assay using directly coated magnetic microparticles
- Sample matrix: Serum, plasma
- Sample volume: 10 µl
- Incubation time: 20 min (10 min + 10 min)
- Measuring range: 0.3 - 1000 U/ml
- Detection Limit: 0.3 U/ml
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
808.075 |
BRAHMS CA 15-3 |
KRYPTOR TRACE Technology |
75 test kit |
Serum |
|
314301 |
Liaison CA 15-3 |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum, plasma |
|
R0054 |
CA 15-3 IRMA |
IRMA, Coated Tubes (RIA) |
50 Tubes |
Serum |
|
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
CA 19-9 |
|
|
|
|
|
|
CA19-9 is used for the diagnosis, follow-up and therapy control in patients with excretory
pancreatic cancer, hepatobiliary and gastric cancer. It is also used for the
early detection of recurrence of disease or metastasis |
|
|
|
|
|
|
|
BRAHMS Kryptor CA 19-9 |
|
|
|
- TRACE technology (Time resolved amplified cryptate emission)
- Sample matrix: Serum
- Diluent included in kit
- Sample volume: 50 µl
- Incubation time: 14 min
- Direct measuring range: 1.2 - 700 U/ml
- Range with automated dilution: 1.2 – 600 000 U/ml
- Detection Limit: 1.2 U/ml
- Intra – assay and Inter-assay coefficients of variation are 1.4 – 3.0 % and 4.8 – 5.9 % , respectively
|
|
|
|
DiaSorin Liaison CA 19-9 |
|
|
|
- 2-step immunoluminometric sandwich assay using directly coated magnetic microparticles
- Sample matrix: Serum, plasma
- Sample volume: 100 µl
- Incubation time: 20 min (10 min + 10 min)
- Measuring range: 0.3 - 1000 U/ml
- Detection Limit: 0.3 U/ml
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
807.100 |
BRAHMS CA 19-9 |
KRYPTOR TRACE Technology |
100 test kit |
Serum |
|
314171 |
Liaison CA 19-9 |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum, Plasma |
|
R0055 |
CA19-9 IRMA |
IRMA, Coated Tubes (RIA) |
50 Tubes |
Serum |
|
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
|
|
|
|
|
Monitor therapy and detect recurrence in patients with CA 72-4-positive cancer
(gastrointestinal cancers) |
|
|
|
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
R0056 |
CA 72-4 IRMA |
IRMA, Coated Tubes (RIA) |
50 Tubes |
Serum |
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
Calcitonin |
|
|
|
|
|
|
Calcitonin is a tumor marker elevated in cases of medullary thyroid carcinoma and C-cell hyperplasia and is used in the diagnosis of these conditions. Medullary thyroid carcinoma (MTC) is a tumor of the CT-producing C-cells of the thyroid gland. Although a rare tumor, it can occur in a familial pattern as part of MEN (Multiple Endocrine Neoplasia) type II syndrome. These tumors usually produce diagnostically elevated serum concentrations of CT. Therefore, the immunoassay for CT in serum can be used to diagnose the presence of MTC with an exceptional degree of accuracy and specificity. |
|
|
|
|
|
|
|
DiaSorin Liaison Calcitonin |
|
|
|
- Direct, two-site, sandwich type immunoluminometric assay using directly coated magnetic microparticle
- Sample matrix: Serum
- Sample volume: 150 µl
- Incubation time: 30 minutes
- Measuring range: 1.0 - 2000 pg/ml
- Detection Limit: 1.0 pg/ml
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
310940 |
Liaison Calcitonin |
Direct, two-site, sandwich immunoluminometric assay |
100 test kit |
Serum |
|
|
BRAHMS Calcitonin |
RIA |
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
|
|
|
|
|
Carcinoembryonic antigen (CEA) is used for colorectal cancer in the long-term follow-up of patients in remission, the evaluation of initial treatment efficacy and the early detection of recurrence or metastasis. Prognosis with a particular significant correlation in Duke’s S and D stages. CEA can also be found in other the following types of cancer (digestive tract, glanular cancer, breast, lung, ovary, bladder and thyroid) |
|
|
|
|
|
|
|
BRAHMS Kryptor CEA |
|
|
|
- TRACE technology (Time resolved amplified cryptate emission)
- Sample matrix: Serum, plasma (heparin/EDTA)
- Diluent included in kit
- Sample volume: 70 µl
- Incubation time: 39 min
- Direct measuring range: 0.2 – 160 ng/ml
- Range with automated dilution: 0.2 – 100 000 ng/ml
- Detection Limit: 0.2 ng/ml
- Intra – assay and Inter-assay coefficients of variation are 1.7 – 1.8 % and 3.3 – 4.9 % , respectively
|
|
|
|
DiaSorin Liaison CEA |
|
|
|
- 2-step immunoluminometric sandwich assay using directly coated magnetic microparticles
- Sample matrix: Serum, plasma
- Sample volume: 50 µl
- Incubation time: 20 min (10 min + 10 min)
- Measuring range: 0.2 - 1000 U/ml
- Detection Limit: 0.2 U/ml
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
817.100 |
BRAHMS CEA |
KRYPTOR TRACE Technology |
100 test kit |
Serum |
|
314311 |
Liaison CEA |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum, plasma |
|
324321 |
IRMA-coat CEA |
IRMA Coated Tube (RIA) |
100 Tunes |
Serum, plasma |
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
CYFRA 21-1 |
|
|
|
|
|
|
CYFRA 21-1 is used for the therapy monitoring and follow-up in patients
suffering from Non-small Cell Lung Cancer (NSCLC). CYFRA 21-1 is also used for
the prognosis factor for tumor stages I – III A vs III B in NSCLC and the
follow-up control in urinary bladder cancer |
|
|
|
|
|
|
|
Diasorin Liaison CYFRA 21-1 |
|
|
|
- TRACE technology (Time resolved amplified cryptate emission)
- Sample matrix: Serum, plasma (heparin/EDTA)
- Diluent included in kit
- Sample volume: 70 µl
- Incubation time: 19 min
- Direct measuring range: 0.1 – 35 ng/ml
- Range with automated dilution: 0.1 – 4000 ng/ml
- Detection Limit: 0.1 ng/ml
- Intra – assay and Inter-assay coefficients of variation are 2.3 - 3.6 % and 5.8 – 6.5 % , respectively
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
811.050 |
BRAHMS CYFRA 21-1 |
KRYPTOR TRACE Technology |
50 test kit |
Serum, plasma (heparin/EDTA) |
|
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
|
|
|
|
|
Determination of β2-Microglobulin is used to monitor lymphoproliferative
diseases (multiple myeloma, chronic lymphocytic lymphoma, non-Hodgkin’s
lymphoma, Hodgkin’s disease) and to assess the renal function. In infectious
diseases and inflammations serum β2-Microglobulin values can be elevated. |
|
|
|
|
|
|
|
DiaSorin Liaison Β2 – Microglobulin |
|
|
|
- 1-step immunoluminometric sandwich assay using directly coated magnetic microparticles
- Sample matrix: Serum, plasma, Urine
- Sample volume: 10 µl
- Incubation time: 10 min
- Measuring range: 0.12 – 40 mg/L
- Detection Limit: 0.12 mg/L
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
314501 |
Liaison β2 - Microglobulin |
1-step immunoluminometric sandwich assay |
100 test kit |
Serum, plasma, Urine |
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
NSE |
|
|
|
|
|
|
Neuron specific enolase (NSE) in Small Cell Lung Carcinoma (SCLC) is used for the differential diagnosis, follow-up and therapy control. NSE is also used in neoroblastoma for follow-up and therapy control. |
|
|
|
|
|
|
|
BRAHMS Kryptor NSE |
|
|
|
- TRACE technology (Time resolved amplified cryptate emission)
- Sample matrix: Serum
- Diluent included in kit
- Sample volume: 70 µl
- Incubation time: 59 min
- Direct measuring range: 0.8 – 200 ng/ml
- Range with automated dilution: 0.8 – 10 000 ng/ml
- Detection Limit: 0.8 ng/ml
- Intra – assay and Inter-assay coefficients of variation are 1.5 – 2.9 % and 2.9 – 5.0 % , respectively
|
|
|
|
Diasorin Liaison NSE |
|
|
|
- 1-step immunoluminometric sandwich assay using directly coated magnetic microparticles
- Sample matrix: Serum
- Sample volume: 25 µl
- Incubation time: 10 min
- Measuring range: 0.04 – 200 µg/L
- Detection Limit: 0.04 µg/L
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
821.050 |
BRAHMS NSE |
KRYPTOR TRACE Technology |
50 test kit |
Serum |
|
314561 |
Liaison NSE |
1-step immunoluminometric sandwich assay |
100 test kit |
Serum |
|
324560 |
Prolifigen NSE IRMA |
IRMA, Coated Tubes (RIA) |
50 Beads |
Serum |
|
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
|
|
|
|
|
Prostatic acid phosphatase (PAP) in combination with PSA or in cases of
non-elevated PSA levels is used for the monitoring of patients with prostate
cancer, detection of recurrence and follow-up of post therapeutic respoNSE. A
prostate cancer with a high PAP level is related in more than 90% of cases to
lymphnode involvement. |
|
|
|
|
|
|
|
BRAHMS Kryptor PAP |
|
|
|
- TRACE technology (Time resolved amplified cryptate emission)
- Sample matrix: Serum
- Diluent included in kit
- Sample volume: 50 µl
- Incubation time: 29 min
- Direct measuring range: 0.1 – 50 ng/ml
- Range with automated dilution: 0.1 – 15 000 ng/ml
- Detection Limit: 0.1 ng/ml
- Intra – assay and Inter-assay coefficients of variation are 0.7 – 2.4 % and 2.4 – 3.0 % , respectively
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
822.050 |
BRAHMS PAP |
KRYPTOR TRACE Technology |
50 test kit |
Serum |
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
Total PSA |
|
|
|
|
|
|
Prostate specific antigen (Total PSA) is used in Prostate cancer for therapy
monitoring and follow-up control. Total PSA is also used for the early detection
of relapse, especially after radical prostatectomy and for the screening of risk
groups |
|
|
|
|
|
|
|
BRAHMS Kryptor Total PSA |
|
|
|
- TRACE technology (Time resolved amplified cryptate emission)
- Sample matrix: Serum
- Diluent included in kit
- Sample volume: 50 µl
- Incubation time: 19 min
- Direct measuring range: 0 – 70 ng/ml
- Range with automated dilution: 0 – 100 000 ng/ml
- Detection Limit: 0.04 ng/ml
- Intra – assay and Inter-assay coefficients of variation are 0.6 – 1.5 % and 2.1 % , respectively
|
|
|
|
DiaSorin Liaison Total PSA |
|
|
|
- 2-step immunoluminometric sandwich assay using directly coated magnetic microparticles
- Sample matrix: Serum, Plasma
- Sample volume: 50 µl
- Incubation time: 20 min (10 min + 10 min)
- Measuring range: 0.09 – 300 ng/L
- Detection Limit: 0.09 ng/L
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
810.100 |
BRAHMS Total PSA |
KRYPTOR TRACE Technology |
100 test kit |
Serum |
|
314381 |
Liaison PSA |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum, Plasma |
|
R0014 |
PSA total IRMA |
IRMA, Coated Tubes (RIA) |
100 Tubes |
Serum, Plasma |
|
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
|
|
|
|
|
Free PSA is used in combination with Total PSA for the improved discrimination
between prostate cancer and BPH to reduce the number of unnecessary biopsies.
Free PSA is also used in combination with PSA for increased sensitivity and
specificity for the detection of prostate cancer. |
|
|
|
|
|
|
|
BRAHMS Kryptor Free PSA |
|
|
|
- TRACE technology (Time resolved amplified cryptate emission)
- Sample matrix: Serum, plasma (heparin/EDTA)
- Diluent included in kit
- Sample volume: 70 µl
- Incubation time: 29 min
- Direct measuring range: 0 – 15 ng/ml
- Detection Limit: 0.02 ng/ml
- Intra – assay and Inter-assay coefficients of variation are 0.5 – 5.2 % and 1.5 – 5.8 % , respectively
|
|
|
|
DiaSorin Liaison Free PSA |
|
|
|
- 1-step immunoluminometric sandwich assay using directly coated magnetic microparticles
- Sample matrix: Serum, Plasma
- Sample volume: 50 µl
- Incubation time: 10 minutes
- Measuring range: 0.04 – 25 ng/L
- Detection Limit: 0.04 ng/L
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
867.050 |
BRAHMS Free PSA |
KRYPTOR TRACE Technology |
50 test kit |
Serum |
|
314391 |
Liaison fPSA |
1-step immunoluminometric sandwich assay |
100 test kit |
Serum, plasma |
|
R0015 |
PSA free IRMA |
IRMA, Coated Tubes (RIA) |
50 Tubes |
Serum, plasma |
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
S100 |
|
|
|
|
|
|
S-100 is a reliable tumor marker mainly in metastatic melanoma where it reflects
the tumor load and prognosis. S-100 has also been described to be a valuable
marker for monitoring and follow-up of melanoma patients. S-100 follows the
course of the disease and has been shown to be an early indicator of relapse. It
could therefore be a valuable adjunct to imaging and clinical assessment. |
|
|
|
|
|
|
|
Another important clinical application for S-100 is as a marker for different
forms of cerebral lesions. Clinical studies have demonstrated an immediate
increase of S-100 in the circulation after a brain injury indicating a fast
release of brain S-100 into the blood. |
|
|
|
|
|
|
|
S-100B is a very sensitive marker for an injury of the brain caused by head
trauma and is released at the time of the primary injury. The level in serum
strongly correlates with the severity of the primary trauma and the outcome of
the patient. In patients with global cerebral ischemia, it has been reported
that a positive value in the serum 24 hours after ischemia is an independent
predictor of not regaining consciousness. S-100 has also been shown to be a
useful marker in stroke and birth asphyxia. |
|
|
|
|
|
|
|
DiaSorin Liaison S100 |
|
|
|
- 2-step immunoluminometric sandwich assay using directly coated magnetic microparticles
- Sample matrix: Serum, CSF
- Sample volume: 100 µl
- Incubation time: 20 min (10 min + 10 min)
- Measuring range: 0.02 – 30 µg/L
- Detection Limit: 0.02 µg/L
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
314701 |
Liaison S100 |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum, CSF |
|
364701 |
S100 ELISA |
ELISA |
96 wells |
Serum, CSF |
|
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
|
|
|
|
|
Squamous cell carcinoma (SCC) is used in cervical cancer for the long-term
follow-up of patients in remission. SCC is used in the evaluation of initial
treatment efficacy in cervical cancer and the detection of recurrence or
metastasis. SCC can also be found in other types of cancer (squamous cell lung
cancer, head and neck cancer, esophageal cancer). |
|
|
|
|
|
|
|
BRAHMS Kryptor SCC |
|
|
|
- TRACE technology (Time resolved amplified cryptate emission)
- Sample matrix: Serum
- Diluent included in kit
- Sample volume: 50 µl
- Incubation time: 44 min
- Direct measuring range: 0.1 – 100 µg/L
- Range with automated dilution: 0.1 – 500 µg/L
- Detection Limit: 0.1 µg/L
- Intra – assay and Inter-assay coefficients of variation are 1.8 – 2.3 % and 3.5 – 4.3 % , respectively
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
812.050 |
BRAHMS SCC |
KRYPTOR TRACE Technology |
50 test kit |
Serum |
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
TK |
|
|
|
|
|
|
Thymidine Kinase (TK) is an essential enzyme which is expressed in cell division
activity. An increased level of cell division is linked to malignant tumor
diseases, such as leukemia and lymphomas. |
|
|
|
|
|
|
|
DiaSorin Liaison TK |
|
|
|
- Indirect, modified 2-step competitive chemiluminescence immunoassay
- Sample matrix: Serum, EDTA Plasma
- Sample volume: 200 µl
- Incubation time: 60 min
- Measuring range: 0.5 – 100 U/L
- Detection Limit: 0.5 U/L
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
310960 |
Liaison TK |
2-step competitive chemiluminescent immunoassay |
100 test kit |
Serum, EDTA plasma |
|
324250 |
Prolifigen TK-REA |
REA Separator Tablets (RIA) |
50 Tables |
Serum |
|
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
|
|
|
|
|
Tissue polypeptide antigen (TPA®) in human serum is used for the management of
patients with tumors arising from epithelial cells, e.g. carcinomas of the lung,
breast, gastrointestinal tract, and urinary bladder. |
|
|
|
|
|
|
|
DiaSorin Liaison TPA-M |
|
|
|
- 2-step immunoluminometric sandwich assay using directly coated magnetic
microparticles
- Sample matrix: Serum
- Sample volume: 100 µl
- Incubation time: 20 min (10 min + 10 min)
- Measuring range: 2 – 4000 U/L
- Detection Limit: 2 U/L
|
|
|
|
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
314121 |
Liaison TPA-M |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum |
|
324121 |
Prolifigen TPA-M IRMA |
IRMA, Coated Tubes (RIA) |
100 Beads |
Serum |
|
|
|
|
|
|
|
Back To Top |
|
|
|
|
|
|
|
|
|
 |